<p>Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy</p>

Male 0301 basic medicine Medicine (General) Curcumin Polymers Hyaluronic acid Proton Magnetic Resonance Spectroscopy Mice, Nude Antineoplastic Agents Bone Neoplasms 03 medical and health sciences R5-920 Drug Delivery Systems International Journal of Nanomedicine Cell Line, Tumor Animals Humans Hyaluronic Acid Particle Size Micelles Original Research Drug Carriers Osteosarcoma Alendronate 3. Good health Drug Liberation Stearic Acids
DOI: 10.2147/ijn.s211981 Publication Date: 2019-08-08T22:27:37Z
ABSTRACT
Introduction: Curcumin (CUR) is a general ingredient of traditional Chinese medicine, which has potential antitumor effects. However, its use clinically been limited due to low aqueous solubility and bioavailability. In order improve the therapeutic effect CUR on osteosarcoma (i.e., bone cancer), multifunctional micelle was developed here by combining active accumulating ability with tumor CD44 targeting capacity. Methods: The loaded micelles were self-assembled using alendronate-hyaluronic acid-octadecanoic acid (ALN-HA-C18) as an amphiphilic material. obtained characterized for size drug loading. addition, in vitro release behavior investigated under PBS (pH 5.7) medium containing 1% Tween 80 at 37℃. Furthermore, hydroxyapatite (the major inorganic component bone) affinity experiment studied. activity evaluated. Finally, anti-tumor efficiency Results: loading ALN-HA-C18 about 118 ± 3.6 nm 6 1.2%, respectively. released from sustained manner after 12 h. indicated that exhibited high bone. much higher cytotoxic against MG-63 cells compared free CUR. effectively delayed growth properties bearing mice Conclusion: present study suggested novel promising delivery hydrophobic anticancer Keywords: curcumin, alendronate, hyaluronic acid,
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (63)